Company Valuation: Edwards Lifesciences Corporation

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 80,883 46,128 46,246 43,663 49,471 48,183 - -
Change - -42.97% 0.25% -5.58% 13.3% -2.6% - -
Enterprise Value (EV) 1 80,616 45,956 45,198 40,285 45,843 44,687 43,173 41,407
Change - -42.99% -1.65% -10.87% 13.8% -2.52% -3.39% -4.09%
P/E 54.4x 30.6x 33.2x 10.6x 46.6x 33.1x 25.3x 22.5x
PBR 13.9x 7.82x 6.99x 4.36x 4.79x 4.59x 3.98x 3.69x
PEG - 12.14x -5.79x 0x -0.6x 0.9x 0.8x 1.8x
Capitalization / Revenue 15.5x 8.57x 7.7x 8.03x 8.15x 7.13x 6.49x 5.89x
EV / Revenue 15.4x 8.54x 7.53x 7.41x 7.56x 6.61x 5.81x 5.06x
EV / EBITDA 46.6x 23.7x 24.1x 24.1x 25.5x 20.9x 18.1x 15.4x
EV / EBIT 50.6x 25.6x 26.1x 26.6x 27.9x 22.7x 19.5x 16.7x
EV / FCF 57.3x 47.2x 47.9x 139x 34.3x 52.6x 26.8x 22.8x
FCF Yield 1.74% 2.12% 2.09% 0.72% 2.91% 1.9% 3.73% 4.39%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 2.38 2.44 2.3 6.97 1.83 2.531 3.303 3.718
Distribution rate - - - - - - - -
Net sales 1 5,232 5,382 6,005 5,440 6,068 6,759 7,429 8,177
EBITDA 1 1,729 1,936 1,879 1,670 1,800 2,137 2,383 2,687
EBIT 1 1,594 1,796 1,734 1,514 1,644 1,971 2,212 2,484
Net income 1 1,503 1,522 1,402 4,175 1,074 1,435 1,895 2,120
Net Debt 1 -267 -172.7 -1,048 -3,378 -3,628 -3,496 -5,010 -6,775
Reference price 2 129.55 74.61 76.25 74.03 85.25 83.68 83.68 83.68
Nbr of stocks (in thousands) 624,334 618,260 606,500 589,800 580,300 575,800 - -
Announcement Date 26/01/22 31/01/23 06/02/24 11/02/25 10/02/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
32.54x6.61x20.93x-.--% 48.18B
28.74x5.14x19.72x0.32% 214B
33.22x6.08x19.24x0.74% 140B
39.64x10.29x22.77x-.--% 128B
16.48x3.47x11.19x-.--% 68.46B
19.04x2.18x11.3x2.76% 45.56B
27.33x5.44x18.58x0.73% 39.69B
46.53x6.48x19.91x-.--% 37.69B
19.73x5.19x13.32x1.16% 30.14B
41.17x6.5x23.12x-.--% 29.2B
Average 30.44x 5.74x 18.01x 0.57% 78.09B
Weighted average by Cap. 30.83x 6.06x 18.80x 0.46%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. EW Stock
  4. Valuation Edwards Lifesciences Corporation